BRUCE WILSON DANA, M.D.

Plain English
This study looked at the effects of CBD-rich cannabis oil on children with Autism Spectrum Disorder (ASD) who also showed symptoms of Attention Deficit Hyperactivity Disorder (ADHD). Among the 53 children assessed after three to six months, significant improvements were noted in areas like hyperactivity and emotional control, with a strong statistical significance (p < 0.001). These findings suggest that CBD oil may help reduce ADHD symptoms in these children, highlighting the need for further research to confirm these results and find the best doses. Who this helps: This helps children with ASD and ADHD and their families.

Plain English
This study examined the tiny organisms living in freshwater and sediment environments to see how they are affected by treated wastewater. Researchers found that sediment communities had more diversity and stability compared to freshwater communities. When exposed to treated wastewater, freshwater organisms initially increased in variety but later returned closer to their original state, while sediment communities showed little change. Understanding these differences is important for monitoring the impact of wastewater on aquatic ecosystems. Who this helps: This benefits environmental scientists and conservationists working to protect water quality.

Plain English
This study looked at how healthcare providers for adults with mental illness are connected in a U.S. state. Researchers found that a major network included 21% of providers and 97% of patients, revealing different levels of provider communities defined by size, types of providers, and their network connections. Understanding these networks can help improve care for patients by revealing how effective provider relationships are, but more research is needed to create better tools for policymakers. Who this helps: This helps patients with mental illness and the doctors who treat them.

Plain English
This study looked at how financial incentives for addiction treatment programs in Maine affected waiting times and the types of clients they accepted. Researchers found that, instead of reducing waiting times as intended, the average waiting time actually increased for everyone, and clients were more likely to have severe substance use issues regardless of whether their programs received incentives. This matters because it suggests that simply offering financial rewards is not enough to improve access or outcomes for those needing treatment. Who this helps: Patients seeking addiction treatment.

Plain English
This study looked at how ascorbic acid (vitamin C) is transported in the eyes of humans compared to mice. Researchers found that a specific transporter for ascorbic acid (SVCT2) is present in humans but not in mice, while another transporter (GLUT1) shows different patterns of expression in both species. This difference helps to explain why humans have higher levels of ascorbic acid in their eye fluids than mice do. Who this helps: This information benefits researchers and clinicians focusing on eye health and treatments related to antioxidants.

Plain English
This study looked at a special type of structure made of metal gratings that can produce two closely spaced energy peaks in light absorption, known as double Fano resonance. The researchers found that by changing the design of the gratings or the angle of incoming light, they could control the position and shape of these energy peaks, which could sharpen how light interacts with the material. This matters because it can improve the performance of sensors and devices that rely on precise light manipulation. Who this helps: This helps engineers and scientists developing advanced sensors and optical devices.

Plain English
This study talks about improving how audits are done for pharmaceutical manufacturers by focusing on the most important parts of their quality systems. The authors propose a risk-based approach, which means that audits will concentrate on areas that are more likely to have issues rather than trying to cover everything every time. This is important because it helps manufacturers ensure they meet quality standards more effectively and efficiently, which leads to better products for patients. Who this helps: This helps patients by ensuring the medications they receive are safe and effective.

Plain English
This study examined how two solitary pulses (SPs) interact in a system where they are linked but have opposing characteristics. The researchers found that these pulse pairs can maintain a stable, breathing pattern over time under certain conditions. Specifically, when the pulses are well-matched in frequency, they stay organized, but strong nonlinear effects can disrupt this stability. Who this helps: This research benefits scientists and engineers working on advanced communication technologies and signal processing.

Plain English
This study explored how laser-activated gold nanoparticles affect pancreatic cancer cells. Researchers found that when these nanoparticles were exposed to a specific laser, they increased their uptake by the cancer cells, causing harmful changes in the cells' mitochondria. Specifically, they noticed mitochondrial swelling and changes in membrane function, which could lead to the cells' death. This advancement could greatly improve targeted therapies for pancreatic cancer. Who this helps: Patients with pancreatic cancer.

Plain English
This case report details a patient who had blood clots stuck in a part of the heart called the Chiari network, which made them hard to treat with standard clot-busting medications. The doctors successfully removed the clots during heart surgery, and tests showed the clots were unusually organized and surrounded by a fibrous layer. The patient's levels of a specific protein linked to clot persistence were significantly higher than normal, which likely contributed to the resistance against treatment. Who this helps: This information aids doctors in understanding how certain heart structures and protein levels can affect treatment outcomes for patients with blood clots.

Plain English
This study looked at how effective the drugs cisplatin and DTIC are for treating patients with advanced melanoma that couldn't be surgically removed. Out of 62 patients treated, 14% saw their tumors shrink, but almost all experienced side effects, including severe issues for 67% of patients. The findings highlight that while these drugs can have some benefit, they often come with serious side effects that need careful management. Who this helps: This helps patients with advanced melanoma looking for treatment options and their doctors managing care.

Plain English
This study looked at how effective a specific combination chemotherapy treatment called MACOP-B is for patients with intermediate- or high-grade non-Hodgkin's lymphoma. The researchers treated 109 patients, achieving complete remission in 50% and partial remission in 33%. Serious side effects were common, with over half of the patients experiencing significant blood-related issues and about 29% developing severe mouth sores. Who this helps: This research benefits patients with non-Hodgkin's lymphoma by providing insights into the effectiveness and safety of MACOP-B chemotherapy.

Plain English
This study looked at a treatment approach for primary CNS lymphoma, a type of brain cancer, using a method that temporarily opens the blood-brain barrier to allow for more effective chemotherapy. The researchers found that patients who received this new treatment (group 2) lived for an average of 44.5 months, compared to 17.8 months for those who had standard radiation therapy (group 1). This approach not only increased survival but also helped many patients maintain their cognitive abilities, which is crucial for quality of life. Who this helps: Patients with primary CNS lymphoma will benefit from this new treatment strategy.

Plain English
This study tested a combination of three chemotherapy drugs—mitoxantrone, cisplatin, and methyl-glyoxal bis-guanylhydrazone (MGBG)—on 32 patients with hard-to-treat malignant lymphoma who had already tried one other treatment. They found that 34% of patients responded to the treatment, with three completely and eight partially recovering, but the treatment also caused serious side effects; 63% experienced dangerously low white blood cell counts. This matters because it shows that while there is some benefit to this treatment, the severe side effects can be a major risk for patients. Who this helps: This research helps patients with aggressive lymphoma who have not responded to earlier treatments.

Plain English
This study looked at the effects of a combination chemotherapy treatment using two drugs, cis-platinum and DTIC, on patients with advanced melanoma, a serious skin cancer. Out of 30 patients, 11 showed a positive response to the treatment, which means the tumors either shrank completely (2 patients) or partially (9 patients), resulting in a total response rate of 37%. The treatment's response lasted for an average of about 31 weeks, which is better than previous treatments. However, some patients experienced serious side effects, including issues with their kidneys, nerves, and blood. Who this helps: This helps patients with advanced melanoma by providing information about a potentially more effective treatment option.

Plain English
Researchers studied a large Finnish family in Astoria, Oregon, who were experiencing erythrocytosis, a condition that increases red blood cell levels. They found that 50% of the hemoglobin in these family members had a specific change, replacing a normal part of the hemoglobin with a threonine, which leads to a higher oxygen affinity than normal—a significant finding with an average P50 of 18 torr at body temperature. This matters because understanding this abnormal hemoglobin variant can aid in diagnosing and managing similar cases in other patients. Who this helps: This helps patients with erythrocytosis and their doctors in identifying and managing their condition.

Plain English
This study looked at 12 patients with primary central nervous system lymphoma to explore better ways to diagnose and treat the disease. Researchers found that using CT-guided needle biopsies helped diagnose six patients, and treatment with a combination of chemotherapy and methods to enhance drug delivery through the blood-brain barrier led to a 75% survival rate after one year. These findings highlight the effectiveness of less invasive diagnostic techniques and innovative treatments, showing promise for improved patient outcomes. Who this helps: This benefits patients with primary CNS lymphoma by providing better diagnostic tools and treatment options.

Plain English
This study compared two treatments, megestrol acetate and tamoxifen, for postmenopausal women with advanced breast cancer to see how well they work and if hormone receptor levels affected the outcomes. Among 190 patients, 35% responded to megestrol acetate, while 42% responded to tamoxifen. Notably, the hormone receptor levels did not significantly impact the effectiveness of either treatment, although there was some link between estrogen receptor levels and response in the tamoxifen group. Who this helps: This helps postmenopausal women with advanced breast cancer by informing their treatment options.

Plain English
This study looked at two hormonal therapies, tamoxifen and megestrol acetate, for treating advanced breast cancer that has spread to other parts of the body. Researchers found that both treatments work equally well and have similar side effects, making them both good options for initial treatment. This matters because it provides more choices for patients and their doctors in managing a serious condition. Who this helps: Patients with stage IV breast cancer.

Plain English
This study looked at a combination of three chemotherapy drugs—cisplatin, bleomycin, and methotrexate—in 26 patients with advanced head and neck cancer, many of whom had already undergone surgery or radiation treatment. Out of the patients, 9 (about 35%) showed a small improvement in their condition, but the treatment did not lead to longer survival or complete recovery. While some patients saw benefits, the treatment caused significant side effects, such as severe nausea, vomiting, and lung issues. Who this helps: This information helps doctors and patients understand the limited effectiveness of this chemotherapy regimen for advanced head and neck cancer.

Plain English
This study looked at how well different cancer drugs work against melanoma cells taken from 50 patients with advanced skin cancer. Researchers tested 9 drugs and found that only 19% of the tests showed a significant reduction in cancer cell survival, indicating that these melanoma cells are generally resistant to these treatments. Understanding how these cells respond to drugs can help develop better tests for finding effective treatments for melanoma patients. Who this helps: This helps patients with metastatic melanoma and their doctors by finding more effective treatment options.

Plain English
This study looked at the levels of heparin neutralizing activity (HNA) in patients with heart valve issues. Researchers found that patients with artificial heart valves, especially aortic ones, had higher HNA levels compared to those with mitral or aortic stenosis. This is important because it helps us understand the differences in blood chemistry related to artificial valves, which could impact treatment decisions. Who this helps: This helps doctors managing patients with prosthetic heart valves.

Plain English
This study examined the activity of heparin neutralization in blood plasma, which helps understand blood cell conditions like low or high platelet counts (thrombocytopenia and thrombocytosis). The researchers found that in cases of low platelet counts caused by immune issues or bone marrow problems, the heparin neutralizing activity was lower than normal, while in a different type of low platelet count due to blood clotting issues, it was higher. In cases of high platelet counts, the activity was very high in some situations but normal in others related to certain blood diseases. Who this helps: This information benefits doctors diagnosing and managing patients with blood disorders.

Plain English
This study looked at how certain proteins in the blood, which can neutralize heparin (a blood thinner), are related to heart issues. Researchers found higher levels of these neutralizing proteins in people who recently had a heart attack, had unstable chest pain, or had confirmed coronary artery disease, indicating that blood platelets play a significant role in these conditions. Understanding these levels can help doctors better assess and manage heart disease. Who this helps: This helps patients with coronary artery disease and their doctors in making treatment decisions.